These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 22759593)

  • 1. Bullous pemphigoid induced by contact with a Rhus tree.
    Lee HM; Cho YH; Koo DW; Lee JS
    Eur J Dermatol; 2012; 22(5):683-4. PubMed ID: 22759593
    [No Abstract]   [Full Text] [Related]  

  • 2. Bullous pemphigoid in a transplant recipient: is this a sign of allograft rejection?
    De Simone C; Caldarola G; Castriota M; Salerno MP; Citterio F
    Eur J Dermatol; 2012; 22(2):280-1. PubMed ID: 22381670
    [No Abstract]   [Full Text] [Related]  

  • 3. Bullous pemphigoid associated with type 1 diabetes mellitus responsive to mycophenolate mofetil.
    Sakanoue M; Kawai K; Kanekura T
    J Dermatol; 2012 Oct; 39(10):884-5. PubMed ID: 22168231
    [No Abstract]   [Full Text] [Related]  

  • 4. A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of bullous pemphigoid.
    Beissert S; Werfel T; Frieling U; Böhm M; Sticherling M; Stadler R; Zillikens D; Rzany B; Hunzelmann N; Meurer M; Gollnick H; Ruzicka T; Pillekamp H; Junghans V; Bonsmann G; Luger TA
    Arch Dermatol; 2007 Dec; 143(12):1536-42. PubMed ID: 18087004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Refractory bullous pemphigoid with fatal outcome in a young patient.
    Cruz MJ; Santos P; Morais P; Barreto F; Azevedo F
    Int J Dermatol; 2013 May; 52(5):601-2. PubMed ID: 23590375
    [No Abstract]   [Full Text] [Related]  

  • 6. Bullous pemphigoid treatment review.
    Patton T; Korman NJ
    Expert Opin Pharmacother; 2006 Dec; 7(17):2403-11. PubMed ID: 17109614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful therapy for bullous pemphigoid with mycophenolate mofetil.
    Nousari HC; Griffin WA; Anhalt GJ
    J Am Acad Dermatol; 1998 Sep; 39(3):497-8. PubMed ID: 9738791
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of bullous pemphigoid with enteric-coated mycophenolate sodium.
    Tursen U; Guney A; Kaya T; Ikizoglu G
    J Eur Acad Dermatol Venereol; 2007 Apr; 21(4):542-4. PubMed ID: 17373988
    [No Abstract]   [Full Text] [Related]  

  • 9. A case of refractory antilaminin γ1 pemphigoid successfully treated with dexamethasone and mycophenolate mofetil.
    Zhiliang L; Xiaodong Z; Peiying J; Suying F; Baoxi W
    Int J Dermatol; 2015; 54(5):e194-6. PubMed ID: 25773159
    [No Abstract]   [Full Text] [Related]  

  • 10. Bullous pemphigoid treated with mycophenolate mofetil.
    Böhm M; Beissert S; Schwarz T; Metze D; Luger T
    Lancet; 1997 Feb; 349(9051):541. PubMed ID: 9048797
    [No Abstract]   [Full Text] [Related]  

  • 11. Bullous pemphigoid in adolescence, a rare demographic.
    Brown H; Lamrock E; Jenkins D
    Australas J Dermatol; 2021 Feb; 62(1):e95-e97. PubMed ID: 32935855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Refractory antilaminin γ1 pemphigoid successfully treated with intravenous immunoglobulin and mycophenolate mofetil.
    Alloo A; Strazzula L; Rothschild B; Hawryluk E; Levine D; Hoang MP; Koga H; Hashimoto T; Kroshinsky D
    J Eur Acad Dermatol Venereol; 2014 Oct; 28(10):1401-3. PubMed ID: 24397852
    [No Abstract]   [Full Text] [Related]  

  • 13. Adjuvant therapy of bullous pemphigoid with mycophenolate mofetil: old drug, new use.
    Ratnam KV
    Singapore Med J; 2001 Oct; 42(10):482-4. PubMed ID: 11874153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement of intravenous immunoglobulin therapy for bullous pemphigoid by adding immunosuppressive agents: marked improvement in depletion of circulating autoantibodies.
    Czernik A; Bystryn JC
    Arch Dermatol; 2008 May; 144(5):658-61. PubMed ID: 18490594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative effectiveness of azathioprine or mycophenolate mofetil as an adjuvant for the treatment of bullous pemphigoid.
    Bystryn JC
    Arch Dermatol; 2008 Jul; 144(7):946. PubMed ID: 18645153
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of pemphigus vulgaris and bullous pemphigoid with mycophenolate mofetil monotherapy.
    Grundmann-Kollmann M; Kaskel P; Leiter U; Krähn G; Behrens S; Peter RU; Kerscher M
    Arch Dermatol; 1999 Jun; 135(6):724-5. PubMed ID: 10376713
    [No Abstract]   [Full Text] [Related]  

  • 17. [Bullous pemphigoid: diagnostics and new therapeutic strategies].
    Hofmann SC; Bruckner-Tuderman L
    Dtsch Med Wochenschr; 2006 Feb; 131(8):389-92. PubMed ID: 16479471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bullous pemphigoid following therapy with an oral beta-blocker.
    Perry A; Sparling JD; Pennington M
    J Drugs Dermatol; 2005; 4(6):746-8. PubMed ID: 16302561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of anti-laminin γ1 pemphigoid with mycophenolate mofetil.
    Gawaz A; Metzler G; Hertl M; Hashimoto T; Schaller M
    J Dtsch Dermatol Ges; 2015 Jul; 13(7):696-7. PubMed ID: 26058852
    [No Abstract]   [Full Text] [Related]  

  • 20. High-dose methylprednisolone in the treatment of bullous pemphigoid.
    Siegel J; Eaglstein WH
    Arch Dermatol; 1984 Sep; 120(9):1157-65. PubMed ID: 6383221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.